Related Experiment Videos
Presence and functions of immune components in the tumor microenvironment
1Department of Cell Research and Immunology, Tel Aviv University, Tel Aviv 69978, Israel.
Advances in Experimental Medicine and Biology
|January 5, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Hybridomas from unimmunized individuals.
Immunology today·2014
The FX enzyme is a functional component of lymphocyte activation.
Cellular immunology·2002
A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.
Journal of immunology (Baltimore, Md. : 1950)·2001
The GPI-linked Ly-6 antigen E48 regulates expression levels of the FX enzyme and of E-selectin ligands on head and neck squamous carcinoma cells.
The Journal of biological chemistry·2000
Differential expression of genes by tumor cells of a low or a high malignancy phenotype: the case of murine and human Ly-6 proteins.
Journal of cellular biochemistry. Supplement·2000
Nucleoskeletal Proteins in Early Embryogenesis.
Advances in experimental medicine and biology·2026
Nuclear Dynamics and Its Timing Regulation Revealed by Live-Cell Imaging.
Advances in experimental medicine and biology·2026
Histone Modifications in Mammalian Early Embryos.
Advances in experimental medicine and biology·2026
Oocyte Kinetochores at the Nexus of Meiotic Drive and Segregation Fidelity.
Advances in experimental medicine and biology·2026
Asymmetric Chromosome Establishment and Segregation During Germline Stem Cell Division.
Advances in experimental medicine and biology·2026
Non-random Sister Chromatid Segregation Mediated by Ribosomal DNA in Drosophila Male Germline Stem Cells.
Advances in experimental medicine and biology·2026
Hyper-Intense Tumor Peripheral Accumulation of Antibody-Conjugated Iron Oxide Nanoparticles can Enable Breast Cancer Detection by Magnetic Particle Imaging.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.
Frontiers in oncology·2026